Trial intelligence / Profile preview

Phase 3 randomized open-label study of C019199 versus gemcitabine + docetaxel in osteosarcoma after failure of at least second-line therapy

CTR20261818Phase 3Active

Sponsor

Haixi New Pharma

Start

Jul 2026

Modality

Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1